Research on the Treatment of Diabetes and Diabetic Complications with Human-Derived Mesenchymal Stem Cell Conditioned Medium

未提供0 个研究点目标入组 20 人开始时间: 待定

适应症

试验速览

暂无简介。

•1. Individuals who did not experience satisfactory effects in the treatment of diabetes or diabetic complications with standard therapy.
•2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate.
•Patients meeting the following criteria will be included:
•1. Individuals aged 18 years or older.
•2. Individuals who have undergone at least two tests showing fasting blood glucose levels of >= 126 mg/dl, 75g OGTT 2-hour values of >= 200 mg/dl, or random blood glucose levels of >= 200 mg/dl.
•3. Individuals with normal capacity to consent.
•4. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily.
•5. Individuals for whom the attending physician has recognized the necessity of treatment.

发起方

未提供